Track insider transactions across markets
| 30 days | 90 days | 120 days | |
|---|---|---|---|
| Average return | -5% | 8.2% | 15.1% |
| Success rate | 51% | 68% | 82% |
| Transactions |
26
54% Buy
|
34
71% Buy
|
47
69% Buy
|
| Average return | -52% |
|---|---|
| Success rate | 73% |
| Average holding period | 220 |
| Transactions | 28 |
| Position | Company | Period |
|---|---|---|
| Chief Financial Officer, Senior Vice President | Tricida Inc | April 1, 2017 - |
| Independent Director | ChemoCentryx Inc | Dec. 1, 2009 - |
| Independent Director | Perrigo Company PLC | Nov. 7, 2016 - |
| Independent Director | Genomic Health Inc | June 21, 2016 - Nov. 8, 2019 |
| Director | Sunesis Pharmaceuticals Inc | March 23, 2016 - Dec. 31, 2017 |
Search